Mouraviev V - Search Results

1

A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections.

McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V. McDonald M, et al. Among authors: mouraviev v. Rev Urol. 2017;19(4):213-220. doi: 10.3909/riu0780. Rev Urol. 2017. PMID: 29472825 Free PMC article. Review.

2

An implementation of next generation sequencing for prevention and diagnosis of urinary tract infection in urology.

Mouraviev V, McDonald M. Mouraviev V, et al. Can J Urol. 2018 Jun;25(3):9349-9356. Can J Urol. 2018. PMID: 29900824 Free article.

3

Sipuleucel-T for the Treatment of Patients With Metastatic Castrate-resistant Prostate Cancer: Considerations for Clinical Practice.

Pieczonka CM, Telonis D, Mouraviev V, Albala D. Pieczonka CM, et al. Among authors: mouraviev v. Rev Urol. 2015;17(4):203-10. Rev Urol. 2015. PMID: 26839517 Free PMC article.

4

Rapid and Short-term Extracellular Matrix-mediated In Vitro Culturing of Tumor and Nontumor Human Primary Prostate Cells From Fresh Radical Prostatectomy Tissue.

Chander AC, Manak MS, Varsanik JS, Hogan BJ, Mouraviev V, Zappala SM, Sant GR, Albala DM. Chander AC, et al. Among authors: mouraviev v. Urology. 2017 Jul;105:91-100. doi: 10.1016/j.urology.2017.03.029. Epub 2017 Mar 29. Urology. 2017. PMID: 28365358

5

Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.

James H 3rd, Aleksic I, Bienz MN, Pieczonka C, Iannotta P, Albala D, Mariados N, Mouraviev V, Saad F. James H 3rd, et al. Among authors: mouraviev v. Urology. 2014 Jul;84(1):164-8. doi: 10.1016/j.urology.2013.12.071. Urology. 2014. PMID: 24976229

6

The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.

Mouraviev V, Mariados N, Albala D, Concepcion RS, Shore ND, Sims RB, Emberton M, Pieczonka CM. Mouraviev V, et al. Rev Urol. 2014;16(3):122-30. Rev Urol. 2014. PMID: 25337042 Free PMC article. Review.

7

Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4).

Albala D, Manak MS, Varsanik JS, Rashid HH, Mouraviev V, Zappala SM, Ette E, Kella N, Rieger-Christ KM, Sant GR, Chander AC. Albala D, et al. Among authors: mouraviev v. Urology. 2019 Feb;124:198-206. doi: 10.1016/j.urology.2018.09.032. Epub 2018 Oct 10. Urology. 2019. PMID: 30312670

8

Metagenomics in diagnosis and improved targeted treatment of UTI.

Dixon M, Stefil M, McDonald M, Bjerklund-Johansen TE, Naber K, Wagenlehner F, Mouraviev V. Dixon M, et al. Among authors: mouraviev v. World J Urol. 2020 Jan;38(1):35-43. doi: 10.1007/s00345-019-02731-9. Epub 2019 Apr 3. World J Urol. 2020. PMID: 30944967 Review.

9

Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?

Caire AA, Sun L, Ode O, Stackhouse DA, Maloney K, Donatucci C, Mouraviev V, Polascik TJ, Robertson CN, Albala DM, Moul JW. Caire AA, et al. Among authors: mouraviev v. Urology. 2009 Sep;74(3):643-7. doi: 10.1016/j.urology.2009.02.049. Epub 2009 Jun 7. Urology. 2009. PMID: 19501891

10

Per aspera ad astra (Through hardship to the stars).

Albala DM, Mouraviev V, Samavedi S. Albala DM, et al. Among authors: mouraviev v. J Robot Surg. 2013 Sep;7(3):213-4. doi: 10.1007/s11701-013-0426-z. J Robot Surg. 2013. PMID: 27000916 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page